Head-to-head · free
Quest Diagnostics vs Elevance Health Inc.
DGX vs ELV — return on capital, cash generation, margins and balance sheet side by side.
DGX
2 / 6
measures where DGX leads
ELV
4 / 6
measures where ELV leads
A simple count of which company scores better on each measure — not a recommendation to buy or sell.
| Measure | DGX · FY2025 | ELV · FY2025 |
|---|---|---|
| Revenue | $11.0B | $199.1B |
| Net income | $992.0M | $5.7B |
| Revenue growth (yearly, multi-year) | 0.6% | 9.5% |
| Free cash flow | $1.4B | $3.2B |
| Free cash flow margin | 12.3% | 1.6% |
| Net cash / (debt) | — | — |
| ROIC | 8.5% | — |
| Return on equity | 14.2% | 13.3% |
| Gross margin | 33.2% | — |
| Operating margin | 14.1% | — |
| Net debt / EBITDA | 2.57x | — |
Figures are as reported by each company; latest fiscal year shown.
Where Quest Diagnostics's cash went (FY2025)
- Capital spending
- $527.0M
- Buybacks
- —
- Dividends
- —
- Acquisitions
- —
- Net debt issued / (repaid)
- —
Where Elevance Health Inc.'s cash went (FY2025)
- Capital spending
- $1.1B
- Buybacks
- —
- Dividends
- —
- Acquisitions
- —
- Net debt issued / (repaid)
- —
Ask which business is stronger
"Which one reinvests at higher returns?" "Who carries more risk in its filings?" Get answers drawn straight from both companies' filings.
Compare them free